Methods
For suspected cancer referrals, we adapted the Head and Neck Cancer Risk
Calculator (HaNC-RC)-V.2, generated from 10,244 referrals with the
following diagnostic efficacy metrics: 85% sensitivity, 98.6% negative
predictive value and area under the curve of 0.89. For follow up
patients, a symptom inventory generated from 5,123 follow-up
consultations was used. A customised Excel Data Tool was created,
trialled across professional groups and made freely available for
download at
www.entintegrate.co.uk/entuk2wwtt,
alongside a user guide, protocol and registration link for the project.
Stakeholder support was obtained from national bodies.